文献速递烧伤创面修复

一种新型逆相变热可逆发泡水凝胶载抗生素治疗猪热烧伤模型——一项先导研究

A novel, reverse-phase-shifting, thermoreversible foaming hydrogel containing antibiotics for the treatment of thermal burns in a swine model - A pilot study.
PubMed 文献 · Burns · 2024-03-15

该先导研究在6头约克夏猪上制作8处等大热烧伤创面,随机分为接种与不接种细菌,再随机分为无干预、CI-PRJ012水凝胶和磺胺嘧啶银乳膏三组。伤后7天盲法病理评估显示,CI-PRJ012与磺胺嘧啶银均较无治疗显著减少坏死和细菌(p<0.01),且CI-PRJ012在减少细菌定植方面显著优于磺胺嘧啶银(p<0.02),两者在减少坏死方面无显著差异(p=0.33)。

要点

  • 在猪热烧伤模型中,CI-PRJ012与磺胺嘧啶银均较无治疗显著减少伤后7天坏死和细菌(p<0.01)。
  • CI-PRJ012在减少细菌定植方面显著优于磺胺嘧啶银(p<0.02),在减少坏死方面两者无显著差异(p=0.33)。
  • CI-PRJ012可用室温水轻松去除,作者认为其可能较磺胺嘧啶银具有临床优势。

核心结论

  • 在猪模型中,CI-PRJ012较无治疗减少坏死和细菌定植,表现与磺胺嘧啶银相当,且可用室温水轻松去除,可能提供临床优势。

研究设计与样本

  • 先导研究,在六头约克夏猪上创建八处等大烧伤创面,半数创面随机接受烧伤后细菌接种,随后创面随机分入无干预、CI-PRJ012或磺胺嘧啶银乳膏三组,研究终点由盲法病理学家评估坏死和细菌定植。

主要发现

  • 与无治疗相比,CI-PRJ012和磺胺嘧啶银乳膏在创面创建后7天均显著减少坏死和细菌(p<0.01,两者各自独立)。
  • CI-PRJ012在减少细菌定植方面显著优于磺胺嘧啶银(p<0.02)。
  • 在创面坏死方面,磺胺嘧啶银乳膏与CI-PRJ012之间无显著差异(p=0.33)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study compared a novel topical hydrogel burn dressing (CI-PRJ012) to standard of care (silver sulfadiazine) and to untreated control in a swine thermal burn model, to assess for wound healing properties both in the presence and absence of concomitant bacterial inoculation. METHODS: Eight equal burn wounds were created on six Yorkshire swine. Half the wounds were randomized to post-burn bacterial inoculation. Wounds were subsequently randomized to three treatments groups: no intervention, CI-PRJ012, or silver sulfadiazine cream. At study end, a blinded pathologist evaluated wounds for necrosis and bacterial colonization. RESULTS: When comparing CI-PRJ012 and silver sulfadiazine cream to no treatment, both agents significantly reduced the amount of necrosis and bacteria at 7 days after wound creation (p < 0.01, independently for both). Further, CI-PRJ012 was found to be significantly better than silver sulfadiazine (p < 0.02) in reducing bacterial colonization. For wound necrosis, no significant difference was found between silver sulfadiazine cream and CI-PRJ012 (p = 0.33). CONCLUSIONS: CI-PRJ012 decreases necrosis and bacterial colonization compared to no treatment in a swine model. CI-PRJ012 appeared to perform comparably to silver sulfadiazine. CI-PRJ012, which is easily removed with the application of room-temperature water, may provide clinical advantages over silver sulfadiazine.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Donaldson RI, Armstrong JK, Buchanan OJ, et al. A novel, reverse-phase-shifting, thermoreversible foaming hydrogel containing antibiotics for the treatment of thermal burns in a swine model - A pilot study. Burns. 2024. PMID: 38582695. doi:10.1016/j.burns.2024.03.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。